EUA
ImmuView COVID-19 Antigen Home Test
FDA Emergency Use Authorization · CTK Biotech, Inc. · Apr 30, 2024
Key facts
| Product | ImmuView COVID-19 Antigen Home Test |
|---|---|
| Company | CTK Biotech, Inc. |
| Product type | Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Serial Screening, Single Target |
| Date | Apr 30, 2024 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: